Beyond the Coronary Angiogram: Further Evaluation of the Coronary Vasculature and Endothelial Function
暂无分享,去创建一个
S. Higano | D. Holmes | A. Lerman | K. Garratt | C. Cannan
[1] M. Yanagisawa. The endothelin system. A new target for therapeutic intervention. , 1994, Circulation.
[2] S. Moncada,et al. The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.
[3] V. Fuster,et al. Circulating and Tissue Endothelin Immunoreactivit in Hypercholesterolemic Pigs , 1993, Circulation.
[4] A M Zeiher,et al. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. , 1993, The Journal of clinical investigation.
[5] A. Nitenberg,et al. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. , 1993, The American journal of medicine.
[6] C. Lau,et al. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients , 1993, The Lancet.
[7] A. Takeshita,et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. , 1993, The New England journal of medicine.
[8] D. Harrison,et al. The Nitrovasodilators New Ideas About Old Drugs , 1993, Circulation.
[9] T. Lüscher,et al. Molecular and cellular biology of endothelin and its receptors--Part I. , 1993, Journal of hypertension.
[10] M. Sugimachi,et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[11] R. Rodeheffer,et al. Increased plasma concentrations of endothelin in congestive heart failure in humans. , 1992, Mayo Clinic proceedings.
[12] P. Poole‐Wilson,et al. Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery , 1992, Circulation.
[13] B. Liang. Adenosine receptors and cardiovascular function. , 1992, Trends in cardiovascular medicine.
[14] H. M. Payne,et al. Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.
[15] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[16] T. Fukami,et al. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.
[17] A. Yeung,et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. , 1991, The New England journal of medicine.
[18] M. Hori,et al. Coronary Circulation , 2005 .
[19] A. Lerman,et al. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. , 1991, The New England journal of medicine.
[20] J. Kaski,et al. Mechanisms of coronary artery spasm. , 1991, Trends in cardiovascular medicine.
[21] M. Yanagisawa,et al. Molecular and Cellular Mechanism of Endothelin Regulation: Implications for Vascular Function , 1991, Circulation.
[22] D. Faller,et al. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. , 1991, The Journal of clinical investigation.
[23] S. Moncada,et al. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. , 1991, The Journal of clinical investigation.
[24] A. Lerman,et al. Endothelin Has Biological Actions at Pathophysiological Concentrations , 1991, Circulation.
[25] G. Rubanyi. Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. , 1991, Circulation.
[26] M. Yanagisawa,et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.
[27] H. Drexler,et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.
[28] H. Drexler,et al. Assessment of coronary vasomotor tone in humans. , 1991, Basic research in cardiology.
[29] Y Dohi,et al. Endothelium-dependent control of vascular tone: effects of age, hypertension and lipids. , 1991, Basic research in cardiology.
[30] D. Harrison,et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.
[31] K. Margulies,et al. Endothelin: a new cardiovascular regulatory peptide. , 1990, Mayo Clinic proceedings.
[32] M. Marcus,et al. Understanding the Coronary Circulation Through Studies at the Microvascular Level , 1990, Circulation.
[33] J. Loscalzo,et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.
[34] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.
[35] K. Nakao,et al. Increased plasma endothelin level in patients with essential hypertension. , 1990, The New England journal of medicine.
[36] E. Feigl,et al. Acetylcholine Causes Coronary Vasodilation in Dogs and Baboons , 1989, Circulation research.
[37] M. Clozel,et al. Effects of Endothelin on the Coronary Vascular Bed in Open-Chest Dogs , 1989, Circulation research.
[38] M. Yanagisawa,et al. INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTION , 1989, The Lancet.
[39] P. Yock,et al. Two-dimensional intravascular ultrasound: technical development and initial clinical experience. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[40] M. Yanagisawa,et al. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. , 1989, Biochemical and biophysical research communications.
[41] E. Nabel,et al. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. , 1989, The Journal of clinical investigation.
[42] N. Matsuki,et al. Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Moncada,et al. A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation , 1989, British journal of pharmacology.
[44] M. Redfield,et al. Integrated cardiac, renal, and endocrine actions of endothelin. , 1989, The Journal of clinical investigation.
[45] H. Shimokawa,et al. Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries. , 1988, Circulation.
[46] K. Zitnay,et al. Loss of Selective Endothelial Cell Vasoactive Functions Caused by Hypercholesterolemia in Pig Coronary Arteries , 1988, Circulation research.
[47] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[48] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[49] F. Klocke,et al. Measurements of coronary flow reserve: defining pathophysiology versus making decisions about patient care. , 1987, Circulation.
[50] S. Moncada,et al. ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.
[51] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[52] R. Frye,et al. Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease. , 1987, Journal of the American College of Cardiology.
[53] P. Vanhoutte,et al. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors. , 1987, The Journal of pharmacology and experimental therapeutics.
[54] R. Ballard-Barbash,et al. Marine fish oils: role in prevention of coronary artery disease. , 1987, Mayo Clinic proceedings.
[55] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[56] R. Paul,et al. Eicosonoid metabolism and beta-adrenergic mechanisms in coronary arterial smooth muscle: potential compartmentation of cAMP. , 1986, The American journal of physiology.
[57] R. Thompson,et al. Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. , 1983, The Journal of pharmacology and experimental therapeutics.
[58] R. Furchgott. Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.
[59] F. Murad,et al. Agonist‐Induced Endothelium‐Dependent Relaxation in Rat Thoracic Aorta May Be Mediated through cGMP , 1983, Circulation research.
[60] M. Bertrand,et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.
[61] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[62] C. Londos,et al. Two distinct adenosine-sensitive sites on adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.